{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:07:58Z","timestamp":1792796878650,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":842,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.cmi.2021.09.018","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T21:43:06Z","timestamp":1632778986000},"page":"130-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study"],"prefix":"10.1016","volume":"28","author":[{"given":"David","family":"Shasha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Bareket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne Hershkowitz","family":"Sikron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Gertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Tsamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mossinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Zacay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2021.09.018_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.09.018_bib3","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.09.018_bib6","series-title":"Vaccines and related biological products advisory committee meeting December 10, 2020","year":"2020"},{"key":"10.1016\/j.cmi.2021.09.018_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/jocd.14035","article-title":"Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence?","volume":"20","author":"Bostan","year":"2021","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"10.1016\/j.cmi.2021.09.018_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","article-title":"Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases","volume":"12","author":"Rodriguez-Jimenez","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"SI","key":"10.1016\/j.cmi.2021.09.018_bib9","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1093\/rheumatology\/keab345","article-title":"Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series","volume":"60","author":"Furer","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.cmi.2021.09.018_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41541-021-00336-1","article-title":"Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2","volume":"6","author":"McDonald","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.cmi.2021.09.018_bib11","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3346\/jkms.2021.36.e115","article-title":"Adverse reactions following the first dose of ChAdOx1 nCoV-19 vaccine and BNT162b2 vaccine for healthcare workers in South Korea","volume":"36","author":"Bae","year":"2021","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.cmi.2021.09.018_bib12","article-title":"Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study","author":"Li","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.cmi.2021.09.018_bib13","doi-asserted-by":"crossref","first-page":"i969","DOI":"10.1136\/bmj.i969","article-title":"Analysis of matched case-control studies","volume":"352","author":"Pearce","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2021.09.018_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.09.018_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","article-title":"Bell's palsy and SARS-CoV-2 vaccines","volume":"21","author":"Ozonoff","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2021.09.018_bib16","first-page":"198","article-title":"Epidemiology of bell's palsy in an Italian health district: incidence and case-control study","volume":"30","author":"Monini","year":"2010","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.cmi.2021.09.018_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000455073","article-title":"Bell's palsy: clinical analysis of 372 cases and review of related literature","volume":"77","author":"Zhao","year":"2017","journal-title":"Eur Neurol"},{"key":"10.1016\/j.cmi.2021.09.018_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/brain\/awaa444","article-title":"COVID-19 vaccine and Guillain-Barre syndrome: let's not leap to associations","volume":"144","author":"Lunn","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.cmi.2021.09.018_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.cmi.2021.09.018_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaneurol.2021.1042","article-title":"Helping the public understand adverse events associated with Covid-19 vaccinations: lessons learned from functional neurological disorder","volume":"78","author":"Kim","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cmi.2021.09.018_bib21","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/mus.27251","article-title":"Post COVID-19 vaccine small fiber neuropathy","volume":"64","author":"Waheed","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cmi.2021.09.018_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21005383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21005383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T10:22:06Z","timestamp":1753611726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X21005383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1198743X21005383"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2021.09.018","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2021.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}